CTOs on the Move

Verve Therapeutics

www.vervetx.com

 
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide. Headquartered in Cambridge, Mass., with a research facility in Philadelphia.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Emily Donlon
 Senior Director, Information Technology Profile
Andrew Sheely
 Vice President Information Technology Profile

Funding

Verve Therapeutics raised $58.5M on 05/07/2019
Verve Therapeutics raised $63M on 06/11/2020
Verve Therapeutics raised $94M on 01/19/2021

Similar Companies

Allylix Inc.

Allylix Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Artisan Orthotic Prosthetic Technologies

Artisan Orthotic Prosthetic Technologies is a Tualatin, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hanford Pharmaceuticals

Hanford Pharmaceuticals is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Radix Biosolutions

Radix Biosolutions is a Georgetown, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CereVasc

The CereVasc eShunt™ device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus.